Rolistobart

Rolistobart is a humanized immunoglobulin G4-kappa, anti-LILRB4/CD85k monoclonal antibody. Rolistobart is an immunostimulant and antineoplastic[1].

Product Specifications

CAS Number

[2723442-10-0]

UNSPSC

12352203

Target

Transmembrane Glycoprotein

Type

Inhibitory Antibodies

Related Pathways

Immunology/Inflammation

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/rolistobart.html

Purity

97.78

Solubility

10 mM in DMSO

Smiles

[Rolistobart]

Molecular Weight

(146.62 kDa)

References & Citations

[1]International Nonproprietary Names for Pharmaceutical Substances (INN) . WHO Drug Information, Vol. 36, No. 4, 2022.

Shipping Conditions

Dry Ice

Storage Conditions

-80°C

Scientific Category

Inhibitory Antibodies

Clinical Information

No Development Reported

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

APR04089G-01 50 µL

SLAMF9 Antibody (C-term) [APR04089G]

View Details

APR04089G-02 100 µL

SLAMF9 Antibody (C-term) [APR04089G]

View Details

APR04089G-03 200 µL

SLAMF9 Antibody (C-term) [APR04089G]

View Details

APR04089G-04 400 µL

SLAMF9 Antibody (C-term) [APR04089G]

View Details

MBS1448344-01 0.02 mg (E-Coli)

Recombinant Macaca fascicularis Carboxypeptidase E (CPE)

View Details

MBS1448344-02 0.02 mg (Yeast)

Recombinant Macaca fascicularis Carboxypeptidase E (CPE)

View Details